Expertise in
23
conditions

Dr. James R. Mark

Urology
Fox Chase Cancer Center - Chestnut Hill
8835 Germantown Avenue, 
Philadelphia, PA 
Offers Telehealth
17 Years of Experience
Expertise in
23
conditions
Fox Chase Cancer Center - Chestnut Hill
8835 Germantown Avenue, 
Philadelphia, PA 

Overview

James Mark is a Urologist practicing medicine in Philadelphia, Pennsylvania. He has been practicing medicine for over 17 years.

Dr. Mark is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Bladder Cancer, Ureteroscopy, and Cystectomy.

Dr. Mark is board certified in American Board Of Urology. He is actively involved in clinical research, co-authoring 38 peer reviewed articles and participating in 1 clinical trial.

Graduate Year

2009

Specialties

Urology

Licenses

Urology in NJ

Board Certifications

American Board Of Urology

Fellowships

Fellow in Urologic Oncology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina (Now Atrium Health), 2015-2016

Hospital Affiliations

Chester County Hospital
Temple University Hospital
Temple Health - Chestnut Hill Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Fox Chase Cancer Center - Chestnut Hill
8835 Germantown Avenue, Philadelphia, PA 19118

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 23, 2026
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3

38 Total Publications

Immune-Enhancing Nutrition and Outcomes After Radical Cystectomy: A Randomized Clinical Trial.
Immune-Enhancing Nutrition and Outcomes After Radical Cystectomy: A Randomized Clinical Trial.
Journal: JAMA network open
Published: July 20, 2026
Similar Doctors
Expertise in
24
conditions
Expertise in
24
conditions
Referral may be required

Penn Urology Perelman

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
 (9.2 miles away)
215-662-2891
Languages Spoken:
English
See accepted insurances

Trinity Bivalacqua is a Urologist practicing medicine in Philadelphia, Pennsylvania. Dr. Bivalacqua is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Prostatectomy.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

Huntingdon Pike

8 Huntingdon Pike, 
Rockledge, PA 
 (6.7 miles away)
888-369-2427
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Robert Uzzo is a Urologist practicing medicine in Rockledge, Pennsylvania. Dr. Uzzo is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Renal Oncocytoma, Nephrectomy, and Cystectomy. Dr. Uzzo is board certified in American Board Of Urology.

Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

Fox Chase Cancer Center - Huntingdon Pike

8 Huntingdon Pike, 
Rockledge, PA 
 (6.7 miles away)
888-369-2427
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Alexander Kutikov is a Urologist practicing medicine in Rockledge, Pennsylvania. Dr. Kutikov is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Cystectomy. Dr. Kutikov is board certified in American Board Of Urology.

Frequently Asked Questions about Dr. James R. Mark

How do I make an appointment with Dr. James R. Mark?

You can book an appointment with Dr. James R. Mark by calling their office at 888-369-2427. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. James R. Mark a top-rated expert for Muscle Invasive Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. James R. Mark is classified as an Distinguished expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. James R. Mark specialize in?

While Dr. James R. Mark is a Urology, they have specific expertise in Muscle Invasive Bladder Cancer, Prostate Cancer, and Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. James R. Mark participate in research or clinical trials?

Yes. Dr. James R. Mark has published 38 articles and abstracts on conditions like Muscle Invasive Bladder Cancer. You can view a list of Dr. James R. Mark's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. James R. Mark accept my insurance?

Dr. James R. Mark accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 888-369-2427 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mark's expertise for a condition
ConditionClose
    View All 19 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile